{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-22-008770","form_type":"8-K","ticker":"DRMA","cik":"0001853816","company_name":"Dermata Therapeutics, Inc.","filed_at":"2022-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.883244+00:00","generated_at":"2026-06-24T23:25:22.582349+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Dermata promotes Nardo to Chief Development Officer; CEO takes 20% pay cut","bullets":["Christopher Nardo promoted to SVP, Chief Development Officer effective July 1, 2022.","Nardo granted option for 30,000 shares; vests 25% after one year, then monthly over 36 months.","Nardo's base salary increased to $320,000 from $280,000 per year.","CEO Gerald Proehl reduces salary from $350,000 to $280,000 per year effective same date."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-22-008770","json":"https://secwatch.observer/filing/0001654954-22-008770.json","markdown":"https://secwatch.observer/filing/0001654954-22-008770.md","text":"https://secwatch.observer/filing/0001654954-22-008770.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1853816/000165495422008770/0001654954-22-008770-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1853816/000165495422008770/drma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T23:25:22.582349+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b53d090a38","claim":"Christopher J. Nardo changed role as Senior Vice President, Chief Development Officer at Dermata Therapeutics, Inc..","evidence_excerpt":"Christopher J. Nardo, Ph.D., the Company’s Senior Vice President of Development, was promoted to Senior Vice President, Chief Development Officer, effective July 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1853816/000165495422008770/0001654954-22-008770-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Senior Vice President, Chief Development Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}